Evidence map›Paper›PMID 33159050›Full record

ArticleNature communications2020

LSH mediates gene repression through macroH2A deposition.

Kai Ni, Jianke Ren, Xiaoping Xu, Yafeng He, Richard Finney, Simon M G Braun, Nathaniel A Hathaway, Gerald R Crabtree, Kathrin Muegge

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Histone H2A variants: Diversifying chromatin to ensure genome integrity.Seminars in cell & developmental biology · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Kai NiMouse Cancer Genetics Program, National Cancer Institute, Frederick, MD, 21702, USA.
Jianke RenMouse Cancer Genetics Program, National Cancer Institute, Frederick, MD, 21702, USA.
Xiaoping XuMouse Cancer Genetics Program, National Cancer Institute, Frederick, MD, 21702, USA.
Yafeng HeMouse Cancer Genetics Program, National Cancer Institute, Frederick, MD, 21702, USA.
Richard FinneyCCR Collaborative Bioinformatics Resource, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA.
Simon M G BraunDepartments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Nathaniel A HathawayDivision of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, UNC Eshelman School of Pharmacy, Chapel Hill, NC, 27599, USA.
Gerald R CrabtreeDepartments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID 0000-0001-9685-7911
Kathrin MueggeMouse Cancer Genetics Program, National Cancer Institute, Frederick, MD, 21702, USA. Kathrin.Muegge@nih.gov.ORCID 0000-0003-1396-4282
National Cancer Institute · USHoward Hughes Medical Institute · USLeidos (United States) · USStanford University · USUniversity of North Carolina at Chapel Hill · US

Funding

ATP-Dependent Chromatin Remodeling in Human MalignancyR01CA163915 · NCI · STANFORD UNIVERSITY · PI Gerald R. Crabtree · 2012 to 2026
$5.4M
ATP-Dependent Chromatin Regulation in Neurodevelopment and Human DiseaseR37NS046789 · NINDS · STANFORD UNIVERSITY · PI CRABTREE, GERALD R. · 2013 to 2019
$2.7M
HIJACKING CANCER DRIVERS TO ACTIVATE PROAPOPTOTIC GENES IN DLBCLR01CA276167 · NCI · STANFORD UNIVERSITY · PI Gerald R. Crabtree, NATHANAEL Schiander GRAY · 2023 to 2026
$2.2M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA163915NCI NIH HHS R01 CA276167NINDS NIH HHS R37 NS046789
6 · The paper itself

Abstract

The human Immunodeficiency Centromeric Instability Facial Anomalies (ICF) 4 syndrome is a severe disease with increased mortality caused by mutation in the LSH gene. Although LSH belongs to a family of chromatin remodeling proteins, it remains unknown how LSH mediates its function on chromatin in vivo. Here, we use chemical-induced proximity to rapidly recruit LSH to an engineered locus and find that LSH specifically induces macroH2A1.2 and macroH2A2 deposition in an ATP-dependent manner. Tethering of LSH induces transcriptional repression and silencing is dependent on macroH2A deposition. Loss of LSH decreases macroH2A enrichment at repeat sequences and results in transcriptional reactivation. Likewise, reduction of macroH2A by siRNA interference mimicks transcriptional reactivation. ChIP-seq analysis confirmed that LSH is a major regulator of genome-wide macroH2A distribution. Tethering of ICF4 mutations fails to induce macroH2A deposition and ICF4 patient cells display reduced macroH2A deposition and transcriptional reactivation supporting a pathogenic role for altered marcoH2A deposition. We propose that LSH is a major chromatin modulator of the histone variant macroH2A and that its ability to insert marcoH2A into chromatin and transcriptionally silence is disturbed in the ICF4 syndrome.

Indexed as

AnimalsChromatinDNA HelicasesDown-RegulationFemaleHistonesHumansMaleMicePrimary Immunodeficiency DiseasesTranscription, GeneticChromatinDNA HelicasesHistoneslymphoid specific helicase, mouseMacroh2a1 protein, mouse

Identifiers

PMID33159050
PMCPMC7648012
OpenAlexW3096389104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.